Doses in the US
16 December 2020 07:27It's time for the OCD crowd to start doing the vaccine dose math ;-)
Pfizer (approved and underway) -- we're getting 100 million doses to cover 50 million people, although US gov't is currently negotiating for more.
Moderna (likely to be approved on Friday) -- we're getting 200 million doses to cover 100 million people.
Johnson & Johnson (no data yet) -- unclear what their safety and efficacy is, we'll learn more next month, but if approved we're getting 100 million doses to cover 100 million people (it's a single-dose vaccine).
With only Pfizer and Moderna, we won't have enough doses to meet demand. The tipping point vaccine will be J&J next month, if that one is approved we'll have 250 million people covered by the end of summer, which is probably more than enough given the level of vaccine "hesitation" in the US.
The US pre-funded six different vaccine candidates via Operation Warp Speed. These three are the most promising to date. Two have already flunked out for 2021 and have to redo their trials, could be ready for 2022 instead. I'm not sure yet about the 4th remaining candidate.
So my fingers are crossed for J&J's data next month, they'll make the difference between not enough and enough doses in the US.
Pfizer (approved and underway) -- we're getting 100 million doses to cover 50 million people, although US gov't is currently negotiating for more.
Moderna (likely to be approved on Friday) -- we're getting 200 million doses to cover 100 million people.
Johnson & Johnson (no data yet) -- unclear what their safety and efficacy is, we'll learn more next month, but if approved we're getting 100 million doses to cover 100 million people (it's a single-dose vaccine).
With only Pfizer and Moderna, we won't have enough doses to meet demand. The tipping point vaccine will be J&J next month, if that one is approved we'll have 250 million people covered by the end of summer, which is probably more than enough given the level of vaccine "hesitation" in the US.
The US pre-funded six different vaccine candidates via Operation Warp Speed. These three are the most promising to date. Two have already flunked out for 2021 and have to redo their trials, could be ready for 2022 instead. I'm not sure yet about the 4th remaining candidate.
So my fingers are crossed for J&J's data next month, they'll make the difference between not enough and enough doses in the US.